See All Slides - tctmd.com

Slides

Presentation TCT 2013

Case #2: A Simple Case That Turned To Be An Incredible Nightmare

Presenter: Mohamed Abdelghany

October 30, 2013

Presentation TCT 2013

TCT-123. Preliminary safety and efficacy results from the REALISE trial: REnAL denervatIon by ultraSound transcatheter Emission

Presenter: Gilles Montalescot

October 30, 2013

Presentation TCT 2013

Case Presentation Conclusion: Procedural and Patient Outcomes(3)

Presenter: Andreas Baumbach

October 30, 2013

Presentation TCT 2013

Climbing the Academic Ladder: Pitfalls and Triumphs

Presenter: J. Dawn Abbott

October 30, 2013

Presentation TCT 2013

Primary PCI for STEMI: A Resounding Victory and Future Challenges

Presenter: Gregg Stone

October 30, 2013

Presentation TCT 2013

Vulnerable Plaque Diagnosis by Grayscale and Radiofrequency IVUS (with Case Vignettes)

Presenter: Patrick Calvert

October 30, 2013

Presentation TCT 2013

PCSK9 Inhibitors: Too Good to Be True?

Presenter: Evan Stein

October 30, 2013

Presentation TCT 2013

Are Sham Controls Needed for Future Renal Denervation Studies?

Presenter: Ajay Kirtane

October 30, 2013

Presentation TCT 2013

Focusing Our Priorities: Moving From the Vulnerable Plaque to the Vulnerable Patient

Presenter: Valentin Fuster

October 30, 2013

Presentation TCT 2013

The Role of the Echocardiographer in a Structural Heart Disease Program: Developing a Viable Imaging Program

Presenter: Linda Gillam

October 30, 2013

Advertisement

Slides

Case #2: A Simple Case That Turned To Be An Incredible Nightmare

TCT-123. Preliminary safety and efficacy results from the REALISE trial: REnAL denervatIon by ultraSound transcatheter Emission

Case Presentation Conclusion: Procedural and Patient Outcomes(3)

Climbing the Academic Ladder: Pitfalls and Triumphs

Primary PCI for STEMI: A Resounding Victory and Future Challenges

Vulnerable Plaque Diagnosis by Grayscale and Radiofrequency IVUS (with Case Vignettes)

PCSK9 Inhibitors: Too Good to Be True?

Are Sham Controls Needed for Future Renal Denervation Studies?

Focusing Our Priorities: Moving From the Vulnerable Plaque to the Vulnerable Patient

The Role of the Echocardiographer in a Structural Heart Disease Program: Developing a Viable Imaging Program

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content